Fortrea Holdings (FTRE) Tax Provisions (2022 - 2026)
Fortrea Holdings (FTRE) reported Tax Provisions of $11.3 million for Q1 2026, down 24.16% on a YoY basis from $14.9 million in Q1 2025, and up 464.52% quarter-over-quarter from -$3.1 million in Q4 2025.
Fortrea Holdings (FTRE) Tax Provisions (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Tax Provisions for 5 years, with the latest figure at $11.3 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 24.16% year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at -$400000.0 (down 105.48% YoY), and the FY2025 full-year result was $3.2 million, up 191.43% from the prior year.
- Tax Provisions for Q1 2026 stood at $11.3 million, up from -$3.1 million in the prior quarter.
- The five-year high for Tax Provisions was $17.2 million in Q2 2022, with the low at -$17.3 million in Q3 2024.
- Historically, Tax Provisions has averaged $3.0 million across 5 years, with a median of $4.1 million in 2025.
- Annual changes were most pronounced in 2023 — Tax Provisions sank 215.09% — and 2025, when it surged 263.41%.
- Fortrea Holdings' Tax Provisions stood at $5.3 million in 2022, then slumped by 215.09% to -$6.1 million in 2023, then soared by 83.61% to -$1.0 million in 2024, then tumbled by 210.0% to -$3.1 million in 2025, then surged by 464.52% to $11.3 million in 2026.
- The last three Tax Provisions figures came in at $11.3 million (Q1 2026), -$3.1 million (Q4 2025), and -$12.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 11.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.30 Mn |
| Dec 31, 2025 | -3.10 Mn |
| Sep 30, 2025 | -12.80 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -17.30 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | -6.10 Mn |
| Sep 30, 2023 | -5.80 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 5.30 Mn |
| Sep 30, 2022 | 13.60 Mn |
| Jun 30, 2022 | 17.20 Mn |